Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A rapamycin-selective 25-kDa immunophilin.

A Galat1, W S Lane, R F Standaert

  • 1Department of Chemistry, Harvard University, Cambridge, Massachusetts 02138.

Biochemistry
|March 3, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Threatened Miscarriage.

The Homoeopathic physician·2023
Same author

Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance.

Annales de cardiologie et d'angeiologie·2021
Same author

Modular microfluidics for point-of-care protein purifications.

Lab on a chip·2015
Same author

BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result types.

Nucleic acids research·2014
Same author

Syntheses and discovery of a novel class of cinnamic hydroxamates as histone deacetylase inhibitors by multimodality molecular imaging in living subjects.

Cancer research·2014
Same author

Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells.

Cell death & disease·2013
Same journal

Aromatic Cage-Directed Azide-Methyllysine Photochemistry for Profiling Nonhistone Interacting Partners of the MeCP2 Methyl-CpG-Binding Domain.

Biochemistry·2026
Same journal

Differential Hydroxypyruvate Processing by <i>E. coli</i> and <i>P. aeruginosa</i> DXP Synthases Reveals Preferential Xylulose 5-Phosphate Formation by the <i>P. aeruginosa</i> Enzyme.

Biochemistry·2026
Same journal

Structural and Functional Characterization of Heterologous Nitrogenase Complexes.

Biochemistry·2026
Same journal

Discovery of Bacterial Unspecific Peroxygenases.

Biochemistry·2026
Same journal

Lactate Biology: Subcellular Routing and Chemical Form Define Function.

Biochemistry·2026
Same journal

Nature's Anaerobic Toolkit: Glycyl Radical Enzymes and Their Expanding Functional and Mechanistic Diversity.

Biochemistry·2026
See all related articles

Researchers purified FKBP25, a novel FK506- and rapamycin-binding protein, revealing unique structural features and rotamase activity. Its selective inhibition by rapamycin suggests potential therapeutic applications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • FKBP25 is a newly identified 25-kDa protein belonging to the FK506- and rapamycin-binding protein (FKBP) family.
  • Previous characterization of FKBPs has not included this specific protein, leaving its structure and function unknown.

Purpose of the Study:

  • To purify and characterize FKBP25.
  • To determine the structural and functional properties of FKBP25, including its enzymatic activity and binding affinities.
  • To compare FKBP25 with other known FKBPs, such as FKBP12.

Main Methods:

  • Purification of FKBP25 from calf thymus, brain, and spleen.
  • Amino acid sequencing of a C-terminal peptide.
  • Circular dichroism spectroscopy to predict secondary structure.

Related Experiment Videos

  • Enzymatic assays to measure rotamase activity.
  • Inhibition assays using immunosuppressants like rapamycin and FK506.

    • Main Results:

    • FKBP25 was purified to homogeneity, and its C-terminal sequence was established.
    • The N-terminal domain is novel, while the C-terminal domain shows homology to other FKBPs but possesses a potential nuclear targeting sequence.
    • FKBP25 exhibits rotamase activity, potently inhibited by rapamycin (Ki = 0.9 nM) and FK506 (Ki = 160 nM), but not cyclosporin A.

    Conclusions:

    • FKBP25 is a unique FKBP with distinct structural features, including a potential nuclear localization signal.
    • The protein's rotamase activity and selective inhibition by rapamycin highlight its specific biochemical properties.
    • These findings provide insights into FKBP structure-function relationships and potential therapeutic targeting.